Delivery Order SPE2DB22D1106-SPE2DB25FFAW2
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Uloric 80mg tablets. The award has a ceiling value of $2,990.19 and an ultimate completion date of November 20, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,158.48 firm fixed-price delivery order is for the supply of ULORIC 80 MG TABLET 30S, a generic pharmaceutical product. The contract has a completion date of June 7, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,039.85, is for the delivery of Uloric 40 mg tablets. The contract is a firm-fixed-price, Indefinite Delivery Contract (IDC) that runs through August 15, 2022. AmerisourceBergen is a for-profit organization registered in the System for Award Management (SAM.gov) and has no set-aside...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,155.59, is for the delivery of ULORIC 40 MG TABLET 30S, a medication used to treat gout. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ULORIC 40 MG TABLET 30S. The fixed-price contract has a ceiling value of $2,077.25 and runs through November 2023. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and has no set-aside designation, indicating open competition. This delivery order is likely part of a larger...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,442.07, is a Delivery Order for the supply of ULORIC 80 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of February 13, 2025 and a firm fixed price pricing type. This award is not designated as a set-aside contract. The contract appears to be part of a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $2,810.20, is for the delivery of 4563458673 ULORIC 40 MG TABLET 30S, a pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing arrangement. The award has an ultimate completion date of January 29, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $5,168 to Amerisourcebergen Drug Corporation to supply 4561884118 ULORIC 80 MG TABLET 30S. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania under a contract start and end date of August 21-22, 2023. No subcontractors or set aside designations were indicated. The Defense Logistics Agency functions to provide logistics support...
- This federal contract award, identified as SPE2DB20D2104|SPE2DB24FU92F, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $2,167.06 firm fixed-price delivery order is for the pharmaceutical product Uloric 40 mg tablet 30s. The contract has an ultimate completion date of June 28, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider registered in the System for Award Management (SAM.gov)....
- This federal contract award is for the delivery of ULORIC 40 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,423.79 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on June 10, 2022, with a completion date of June 13, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is registered in the System for Award Management...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFAW2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Uloric 80 mg tablets (30-count packages) under a firm fixed-price contract valued at $18,138.23, with an ultimate completion date of August 1, 2025. This competitively awarded, non-set-aside delivery order represents a continuation of the company's pharmaceutical supply relationship with DLA and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical federal vendor for military and veteran healthcare systems. The company's portfolio of DLA contracts encompasses a broad range of pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies. Uloric is a prescription medication used in the treatment of gout and hyperuricemia, demonstrating the company's capacity to supply specialty pharmaceuticals for federal healthcare programs. This delivery order exemplifies the firm fixed-price, competitively awarded contract structure that characterizes AmerisourceBergen's federal work with DLA, reflecting its demonstrated capability to meet federal procurement standards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.1k | 7/31/25 |